Posted 4/18/2018 8:50 PM (GMT 0)
We've had success stories with Entyvio and UC posted on the forum. Often health insurance requires patients to first fail a tnf-alpha-blocking medication before trying entyvio out. So, that makes those trying entyvio a little more pre-disposed to be the most difficult, non-responsive cases that have failed a lot of other treatments leading up to entyvio (meaning a greater percentage of patients who are most likely to ultimately need a surgery for their UC). I bet entyvio will do well as many more UC patients have entyvio as his/her first biologic.
Yes, all biologics can be adjusted on infusion-frequency and dosage-per-infusion: entyvio: remicade, humira, simponi, etc. Most gasteroenteroligists are of the opinion "well if it worked for remicade, than it should for entyvio..." and that includes patients who get a response but it fades before the next, 8-week treatment. The entyvio concentration and antibody blood tests can help fine-tune dosage, as well.